Yahoo Web Search

  1. Yahoo Finance Results

  2. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MRK. Index (PMI) data, output in the Healthcare sector is rising.

  3. What's in the Cards for Merck KGaA (MKGAF) in Q2 Earnings?

    Zacks via Yahoo FinanceAug 06 13:30 PM

    Merck KGaA MKGAF is scheduled to report second-quarter 2018 results on Aug 9. Merck’s shares have declined 5.3% so far this year compared with the industry’s decrease of 0.5%.

  4. NASDAQ: ACAD) Agenus Inc (NASDAQ: AGEN) Arsanis Inc (NASDAQ: ASNS) BENITEC BIOPHAR/S ADR (NASDAQ: BNTC) Citius Pharmaceuticals Inc (NASDAQ: CTXR) Clementia Pharmaceuticals ...

  5. Pfizer’s PFE strong second-quarter results stole the show this week. Other than that, the European Commission approved Pfizer’s first oncology biosimilar and a second indication for its JAK ...

  6. Agenus Inc. AGEN is expected to report second-quarter 2018 results on Aug 2. In the last reported quarter, the company reported a negative earnings surprise of 50%. In the last ...

  7. Aduro (ADRO) Q2 Loss Narrower Than Expected, Revenues Miss

    Zacks via Yahoo FinanceAug 03 16:07 PM

    The milestone payment was paid for initiation of a phase I study, evaluating Aduros anti-CD27 antibody in combination with Merck’s Keytruda (pembrolizumab) for treatment of adults with ...

  8. All the shares offered are to be sold by the company. The stock fell 6.94 percent to $8.31 in after-hours trading.

  9. For Immediate Release Chicago, IL – August 6, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news ...

  10. Perrigo Company plc PRGO reported second-quarter 2018 adjusted earnings of $1.22 per share, which beat the Zacks Consensus Estimate of $1.21. Net sales in the reported quarter decreased ...

  11. Incyte (INCY) Earnings Miss, Revenues Beat Estimates in Q2

    Zacks via Yahoo FinanceJul 31 20:00 PM

    The company reported a net income of 26 cents in the second quarter of 2018, which missed the Zacks Consensus Estimate of 30 cents and was a penny down from 27 cents reported in the year-ago ...

  1. Ads
    related to Merck & Company, Inc